Monthly Archives: August 2023

Updated COVID Vaccines Will Roll Out Mid-September, Officials Say

Updated COVID Vaccines Will Roll Out Mid-September, Officials Say By Cara Murez HealthDay Reporter FRIDAY, Aug. 25, 2023 — New COVID-19 booster shots, reworked to target variants circulating now, could be available by mid-September. The U.S. Food and Drug Administration is expected to approve them in a few weeks, CNN reported, citing unnamed senior administration officials. The U.S. Centers […]

Signs of Parkinson’s Disease

Gut Troubles Could Be Early Signal of Parkinson’s Disease By Cara Murez HealthDay Reporter FRIDAY, Aug. 25, 2023 — It might not seem like constipation or difficulty swallowing could signal a neurological problem, but new research suggests that these gut conditions could be an early indicator of Parkinson’s disease. Gastrointestinal symptoms are also thought to […]

Millions of Americans May Have COVID

Millions More Americans May Have Long COVID Than Thought By Dennis Thompson HealthDay Reporter WEDNESDAY, Aug. 23, 2023 — Millions of Americans swear they’re suffering the symptoms of long-haul COVID, but are greeted with eye rolls because they never were formally diagnosed with COVID-19. Their claims need to be taken more seriously by physicians, a new […]

Sepsis Kills: Keeping Others Safe

Sepsis Almost Killed Jake Tapper’s Daughter, Alice. Now, She’s Working to Keep Others Safe By Dennis Thompson HealthDay Reporter FRIDAY, Aug. 25, 2023 — Alice Tapper felt deathly ill, suffering from severe abdominal pain, a 102-degree fever and vomiting. Emergency room doctors found that Alice — the daughter of CNN anchor Jake Tapper — had a rapid […]

New Drugs FDA Approves Tyruko

FDA Approves Tyruko FDA Approves Tyruko (natalizumab-sztn), a Biosimilar to Tysabri August 24, 2023 — The U.S. Food and Drug Administration today approved Tyruko (natalizumab-sztn), the first biosimilar to Tysabri (natalizumab) injection for the treatment of adults with relapsing forms of multiple sclerosis (MS). Tyruko, like Tysabri, is also indicated for inducing and maintaining clinical response and remission […]

FDA Alerts: Purchase or Use Certain Drugs

FDA Warns Consumers Not To Purchase or Use Certain Methylsulfonylmethane (MSM) Eye Drops Due to Contamination Audience: Consumers August 22, 2023 — FDA is warning consumers not to purchase and to immediately stop using Dr. Berne’s MSM Drops 5% Solution and LightEyez MSM Eye Drops – Eye Repair due to bacterial contamination, fungal contamination, or both. […]

New Drug Approvals

The following drugs have recently been approved by the FDA. Includes newly approved drugs and new indications for drugs already approved. See also: Generic approvals, Approval process, New indications & dosage forms Tyruko (natalizumab-sztn) Injection Company: Sandoz Inc.Date of Approval: August 24, 2023Treatment for: Multiple Sclerosis, Crohn’s Disease Tyruko (natalizumab-sztn) is an integrin receptor antagonist biosimilar to Tysabri, approved for the treatment […]

×